FDA.reportPublic FDA data

1 ML DHE mesylate 1 MG/ML Auto-Injector

RxCUI
2714308
RxNorm name
1 ML DHE mesylate 1 MG/ML Auto-Injector
Display name
1 ML DHE mesylate 1 MG/ML Auto-Injector
Full name
1 ML DHE mesylate 1 MG/ML Auto-Injector
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:21

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BREKIYADIHYDROERGOTAMINE MESYLATEAmneal Pharmaceuticals LLCcdbf5619-767f-4165-aec2-17bdd92d9ca22025-10-04Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2714308

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
cdbf5619-767f-4165-aec2-17bdd92d9ca21 ML DHE mesylate 1 MG/ML Auto-InjectorSY2These highlights do not include all the information needed to use BREKIYA ® safely and effectively. See full prescribing information for BREKIYA ® . BREKIYA ® (dihydroergotamine mesylate) injection, for subcutaneous use Initial U.S. Approval: 194620251004
cdbf5619-767f-4165-aec2-17bdd92d9ca2dihydroergotamine mesylate 1 MG (equivalent to dihydroergotamine 0.86 MG) per 1 ML Auto-InjectorSY2These highlights do not include all the information needed to use BREKIYA ® safely and effectively. See full prescribing information for BREKIYA ® . BREKIYA ® (dihydroergotamine mesylate) injection, for subcutaneous use Initial U.S. Approval: 194620251004
cdbf5619-767f-4165-aec2-17bdd92d9ca2dihydroergotamine mesylate 1 MG in 1 ML Auto-InjectorPSN2These highlights do not include all the information needed to use BREKIYA ® safely and effectively. See full prescribing information for BREKIYA ® . BREKIYA ® (dihydroergotamine mesylate) injection, for subcutaneous use Initial U.S. Approval: 194620251004
cdbf5619-767f-4165-aec2-17bdd92d9ca21 ML dihydroergotamine mesylate 1 MG/ML Auto-InjectorSCD2These highlights do not include all the information needed to use BREKIYA ® safely and effectively. See full prescribing information for BREKIYA ® . BREKIYA ® (dihydroergotamine mesylate) injection, for subcutaneous use Initial U.S. Approval: 194620251004